Table of Contents Table of Contents
Previous Page  32 / 1082 Next Page
Information
Show Menu
Previous Page 32 / 1082 Next Page
Page Background

S19

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

Taking into account conformality and OAR dose reduction,

ARC-A performed as well as B-VMAT. ARC-A does not

require couch rotation, therefore reducing set-up error

and making it easier to combine with DIBH apparatus

compared to B-VMAT. It should be considered as a

practical alternative to B-VMAT. We found it useful to

have a list of "aspirational" DCs for this planning

comparison. In practice, however, each patient’s OARs

should be set based on their clinical characteristics and

disease location and the best plan should be chosen after

comparison of at least two techniques.

PV-0044 Is involved-node radiotherapy for Hodgkin

lymphoma safe in routine?

A. Boros

1

, R. Sun

1

, J. Arfi Rouche

2

, J. Lazarovici

3

, D.

Ghez

3

, J.M. Michot

3

, A. Beaudré

4

, A. Danu

3

, J. Bosq

5

, V.

Ribrag

3

, R. Mazeron

1

1

Institut de Cancérologie Gustave Roussy, Radiation

Oncology Department, Villejuif, France

2

Institut de Cancérologie Gustave Roussy, Radiology

Department, Villejuif, France

3

Institut de Cancérologie Gustave Roussy, Oncology

Department, Villejuif, France

4

Institut de Cancérologie Gustave Roussy, Radiation

Physicist, Villejuif, France

5

Institut de Cancérologie Gustave Roussy, Pathology

Department, Villejuif, France

Purpose or Objective

Involved-node radiotherapy (INRT) answers the need for

reducing the irradiated volumes in Hodgkin lymphoma

patients, in promising to reduce the risk of late morbidity.

However, this concept, combined with modern

radiotherapy techniques, exposes to risks of geographic

misses. The purpose was to evaluate the efficiency of INRT

in daily routine.

Material and Methods

The data from patients with limited Hodgkin diseases

treated with a combined modality associating

chemotherapy and INRT were reviewed. Eligibility was

restricted to those with Ann-Arbor stage I-II diseases, who

had a PET-CT in treatment position prior to

chemotherapy. Supra diaphragmatic recurrences were

sorted according to radiotherapy fields as in or out-field

and their belonging to a treated lymph nodes area was

examined, with the aim to state if the target would have

been included in an involved-field radiation therapy

(IFRT). Distance relapse was defined as a recurrence

located beyond the diaphragm.

Results

Seventy-four consecutive patients were included.

Histologic subtypes were nodular sclerosis in 91%, mixed

cellularity in 7%, and lymphocyte depleted in 2%. Patients’

mean age at diagnosis was 37.6±13.1 years; median

follow-up, 40.6 months. Initially 88% of the patients had

stage II diseases and the remaining 12%, stage I. According

to the EORTC (European Organization for Research and

Treatment of Cancer) criteria 70% had early unfavorable

diseases and 30%, early favorable diseases. All patients

received ABVD, administrated in 95% of the patients for 3-

4 cycles, followed by BEACOPP after 2 cycles in 2%, or

combined with brentuximab in 5%. The mean RT dose was

30.9±2.0 Gy delivered in 1.8±0.05 Gy fractions. IMRT was

used in 42 %, and 3D conformal radiotherapy in 18%. Deep

inspiration bread hold technique (DIBH) was used in 40%,

with 3D conformal radiotherapy in all but one patient

(IMRT).

A total of 4 patients experienced relapses (crude

incidence: 5.4%), which resulted in 3- and 5-year disease

free survival rates of 96.9% and 93.8%. Three- and 5-year

overall survival rates were 100% and 97.4% respectively.

All four patients had supra diaphragmatic recurrences. In

two patients, they consisted in a mix of in- and out-field

relapses. In-field relapses occurred in regions receiving

30.6 Gy and 32.4 Gy, respectively. In the remaining two

patients, relapses were out-field on both side of the

diaphragm. In 2 patients out of 4, relapses were located

in lymph nodes regions partially irradiated with INRT (1

and 2 areas respectively).

Conclusion

Although the 4 reported relapses comprised out-field

areas, recurrences in partially irradiated lymph node

areas, which would have been potentially covered by IFRT

fields, occurred in 2 patients (2.7%). On the overall, INRT,

implemented in routine, yielded satisfactory outcomes in

regard to published series.

PV-0045 Estimation of internal risk volume for

coronary arteries after motion evaluation with ECG-

gated CT

M. Levis

1

, C. Fiandra

1

, A.R. Filippi

2

, F. Cadoni

1

, V. De

Luca

1

, A. Cannizzaro

3

, D. Garabello

4

, S. Veglia

4

, R.

Ragona

1

, U. Ricardi

1

1

University of Torino, Radiation Oncology, Torino, Italy

2

San Luigi Hospital, Radiation Oncology, Orbassano

Torino, Italy

3

University of Messina, Radiation Oncology, Messina,

Italy

4

A.O.U. Città della Salute e della Scienza, Radiology,

Torino, Italy

Purpose or Objective

Retrospective studies in patients affected with Hodgkin

lymphoma and breast cancer demonstrated a linear

relationship between heart dose and the risk of coronary

artery disease (CAD). In order to spare small structures

such as coronary arteries (CA), a highly precise contouring

is needed; however, heart motion represents an obstacle

for a correct delineation. To date, the entity of motion-

induced CA displacement and margins for internal risk

volume (IRV) are poorly described. Aim of this study was

to quantify CA displacement and then estimate IRV

through the use of ECG-gated CT.

Material and Methods